Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biogen Pharmachem Industries has fixed Friday, 15 May 2026 as the record date to identify shareholders eligible for a bonus issue in the ratio of 1:6 — meaning 1 new equity share of Re.1 each for every 6 existing shares held. The bonus is subject to shareholder approval, which the company is seeking through a postal ballot (including e-voting). The face value of both existing and new shares is Re.1, and the company has made this disclosure under SEBI LODR Regulation 42.
If approved, existing shareholders will receive roughly 1 bonus share for every 6 shares they own, increasing the total share count by about 16.7%. Share price typically adjusts downward on the ex-date to reflect the extra shares, so the overall value usually stays similar in the short term, though it can improve liquidity and retail participation.